| Status: Under consideration by AWMSG Scrutiny Panel | |
Treatment of Friedreich’s ataxia (FA) in adults and adolescents aged 16 years and older. |
|
Medicine details |
|
| Medicine name | omaveloxolone (Skyclarys®) |
| Formulation | 50 mg hard capsule |
| Reference number | 5337 |
| Indication | As above |
| Company | Biogen Idec Ltd |
| BNF chapter | Central nervous system |
| Assessment type | Under consideration |
| Status | Under consideration by AWMSG Scrutiny Panel |
| Scrutiny Panel meeting date | 16/04/2026 |